Efficacy and safety of once daily versus twice daily mesalazine for mild-to-moderate ulcerative colitis: A meta-analysis of randomized controlled trials

BACKGROUND: We aimed to conduct a meta-analysis to evaluate the efficacy and safety between once daily (OD) and twice daily (BD) regime dosing of mesalazine for mild-to-moderate ulcerative colitis (UC). METHODS: PubMed, Embase, the Cochrane library, and Web of Science from 1990 to November 2018 were...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Medicine (Baltimore)
Egile Nagusiak: Zheng, Xin, Zhang, Zhen, Wang, Botao, Li, Jiaxin, Qiu, Chongyang, Zhang, Qi, Wang, Ximo
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Wolters Kluwer Health 2019
Gaiak:
Research Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6456149/
https://ncbi.nlm.nih.gov/pubmed/30946380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000015113
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak